Updated October 17, 2007
Former GSK Exec Joins CeNeRx as Chief Medical Officer
Post a comment
Print this storyE-mail story
Share
Research Triangle Park, N.C. —
Daniel Burch, a former executive with GlaxoSmithKline, has joined startup CeNeRx BioPharma as its executive vice president for research and development as well as chief medical officer.
The lead product for CeNeRx targets depression and anxiety. The company closed on $15 million in venture financing in late 2005.
Burch has 15 years of experience in new medicine development, having worked at GSK, Abbott Laboratories and SmithKline Beecham. At GSK he was senior vice president and head of the neurosciences medicine development center.
A graduate of the Vanderbilt University School of Medicine, he earned an MBA at the Wharton School at the University of Pennsylvania.
Featured
Hot Off The Wire
- Red Hat's new Fedora lead; Cree LED breakthrough; Google, Cisco top 'green' list; Oracle rejects SAP settlement; Yahoo board shakeup
- Will Cisco report progress in its turnaround efforts?
- Cisco server fire threat; Lenovo Android upgrade; cloud startup vs. Cisco; Epic's Blesinski to host awards; Google 'Solve for X'
E-mail Preferences
